Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term-Reference-Cited by-同舟云学术

Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term

Published:2021-10-06 Issue:614 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Katzelnick Leah C.¹²^ORCID,Zambrana Jose Victor³^ORCID,Elizondo Douglas³,Collado Damaris³^ORCID,Garcia Nadezna³,Arguello Sonia³,Mercado Juan Carlos³⁴,Miranda Tatiana³^ORCID,Ampie Oscarlett³^ORCID,Mercado Brenda Lopez³^ORCID,Narvaez César³,Gresh Lionel³^ORCID,Binder Raquel A.¹³^ORCID,Ojeda Sergio³^ORCID,Sanchez Nery³^ORCID,Plazaola Miguel³^ORCID,Latta Krista⁵^ORCID,Schiller Amy⁵^ORCID,Coloma Josefina¹^ORCID,Carrillo Fausto Bustos¹^ORCID,Narvaez Federico³^ORCID,Halloran M. Elizabeth⁶⁷^ORCID,Gordon Aubree⁵^ORCID,Kuan Guillermina³⁸^ORCID,Balmaseda Angel³⁴,Harris Eva¹^ORCID

Affiliation:

1. Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.

2. Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3203, USA.

3. Sustainable Sciences Institute, Managua 14007, Nicaragua.

4. Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua 16064, Nicaragua.

5. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109-2029, USA.

6. Department of Biostatistics, University of Washington, Seattle, WA 98195-1617, USA.

7. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

8. Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua 12014, Nicaragua.

Abstract

Unexpectedly, cross-reactive antibodies are stable or rise after primary dengue and Zika virus infection and wane slowly after secondary infection.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference87 articles.

1. Emerging Infectious Diseases: Threats to Human Health and Global Stability

2. In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

3. Antibody-Dependent Enhancement of Dengue Virus Growth in Human Monocytes as a Risk Factor for Dengue Hemorrhagic Fever

4. RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILAND

5. Antibody-dependent enhancement of severe dengue disease in humans

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination;Journal of Clinical Microbiology;2024-08-28

2. Pooled Cohort Profile: ReCoDID Consortium’s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort;JMIR Public Health and Surveillance;2024-07-23

3. Sentinel Enhanced Dengue Surveillance System — Puerto Rico, 2012–2022;MMWR. Surveillance Summaries;2024-05-30

4. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1;Science Translational Medicine;2024-05-29

5. Continuing development of vaccines and monoclonal antibodies against Zika virus;npj Vaccines;2024-05-24